L-DOPA
Showing 1 - 25 of 3,302
Anhedonia, Depression Trial in Atlanta (Carbidopa Levodopa, Placebo)
Not yet recruiting
- Anhedonia
- Depression
- Carbidopa Levodopa
- Placebo
-
Atlanta, GeorgiaEmory University Hospital
Oct 4, 2023
An Imaging Agent With Positron Emission Tomography/Magnetic
Recruiting
- Recurrent Soft Tissue Sarcoma
- +2 more
- Fluorodopa F 18
- +4 more
-
Jacksonville, FloridaMayo Clinic in Florida
Jan 4, 2023
PET Scanning in Parkinson s Disease
Recruiting
- Schizophrenia
- Parkinson's Disease
- 18F-Fluoro-L-dopa
- O-15 Water
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Glioblastoma Trial in Rochester (radiation, procedure, drug, other)
Recruiting
- Glioblastoma
- Accelerated Hypofractionated Radiation Therapy
- +8 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Mar 24, 2023
MDD, Dysthymia, Depression Trial in New York (L-DOPA, Placebo Oral Tablet)
Suspended
- Major Depressive Disorder
- +2 more
- L-DOPA
- Placebo Oral Tablet
-
New York, New YorkNew York State Psychiatric Institute
Jan 26, 2022
Disorder of Consciousness, Traumatic Brain Injury Trial in New York (Amantadine + L-DOPA, NMDA blocker)
Suspended
- Disorder of Consciousness
- Traumatic Brain Injury
- Amantadine + L-DOPA
- NMDA blocker
-
New York, New YorkWeill Cornell Medicine
Sep 27, 2022
Depressive Disorder, Major Trial (L-dopa/Carbidopa, Placebo)
Not yet recruiting
- Depressive Disorder, Major
- L-dopa/Carbidopa
- Placebo
- (no location specified)
Jun 11, 2023
PTSD, Post Traumatic Stress Disorder Trial in Austin, Madison (L-DOPA, Placebo)
Recruiting
- PTSD
- Post Traumatic Stress Disorder
- L-DOPA
- Placebo
-
Austin, Texas
- +1 more
Jan 12, 2023
Parkinson Trial in Dupnitsa (Opicapone 50 mg, Placebo)
Recruiting
- Parkinson
- Opicapone 50 mg
- Placebo
-
Dupnitsa, BulgariaMedical Centre "Asklepii", OOD
Jul 20, 2021
Malignant Glioma Trial in Rochester (Fluorine-18-L-dihydroxyphenylalanine)
Active, not recruiting
- Malignant Glioma
-
Rochester, MinnesotaMayo Clinic
Oct 10, 2022
Depression, Anhedonia Trial in Atlanta (Carbidopa Levodopa, Placebo)
Recruiting
- Depression
- Anhedonia
- Carbidopa Levodopa
- Placebo
-
Atlanta, GeorgiaEmory University Hospital
Mar 3, 2022
Spinal Cord Injuries Trial in Louisville (5HTP, L-DOPA, Placebo oral tablet)
Recruiting
- Spinal Cord Injuries
- 5HTP
- +3 more
-
Louisville, KentuckyUniversity of Louisville, Kentucky Spinal Cord Injury Research C
Aug 27, 2021
Depressive Disorder Trial in New York (Carbidopa/levodopa, Placebo, Exercise training)
Suspended
- Depressive Disorder
- Carbidopa/levodopa
- +3 more
-
New York, New YorkNew York State Psychiatric Institute
Jan 26, 2022
Late Life Depression, Cognitive Decline, Depressive Disorder, Treatment-Resistant Trial in Nashville (L-Dopa, Placebo)
Recruiting
- Late Life Depression
- +4 more
- L-Dopa
- Placebo
-
Nashville, TennesseeVanderbilt Psychiatric Hospital
Feb 23, 2022
Depression, Cognitive Impairment, Gait Impairment Trial in New York (Carbidopa/levodopa, Placebo)
Suspended
- Depression
- +2 more
- Carbidopa/levodopa
- Placebo
-
New York, New YorkNew York State Psychiatric Institute
Jan 26, 2022
Parkinson's Disease Trial in United States (AFQ056 with L-dopa, Placebo)
Completed
- Parkinson's Disease
- AFQ056 with L-dopa
- Placebo
-
Sunnyvale, California
- +3 more
Dec 15, 2020
Sub-acute Back Pain Trial in Chicago (Naproxen, Carbidopa/Levodopa, Placebo)
Completed
- Sub-acute Back Pain
- Naproxen
- +2 more
-
Chicago, IllinoisNorthwestern University Feinberg School of Medicine
Mar 2, 2021
Brain Metastases, MRI Trial in Angers (F-DOPA PET/CT)
Recruiting
- Brain Metastases
- MRI
- F-DOPA PET/CT
-
Angers, France
- +1 more
Dec 28, 2021
Hyperinsulinism Trial in Saint Louis (18F-Fluoro Dopa PET/MRI Imaging)
Recruiting
- Hyperinsulinism
- 18F-Fluoro Dopa PET/MRI Imaging
-
Saint Louis, MissouriWashington University
Oct 8, 2021
Opicapone Plus Standard of Care in Elderly Parkinson's Disease
Completed
- Parkinson Disease
- Opicapone
- Levodopa (L-DOPA) + Standard care
-
Norwich, Norfolk, United KingdomNorfolk&Norwich University Hospitals
Oct 1, 2021
Parkinson's Disease Trial in Australia (Placebo, L-dopa 35 mg, L-dopa 70mg)
Completed
- Parkinson's Disease
- Placebo
- +4 more
-
Sydney, New South Wales, Australia
- +4 more
Jul 27, 2020
Substance Abuse Pre-Treatment Screening Study
Recruiting
- Cocaine Abuse
- +4 more
- modafinil
- +3 more
-
Houston, TexasUniversity of Texas Medical School- Houston, Dept. of Psychiatry
Oct 12, 2021